Literature DB >> 17457933

Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.

Paul J Thuluvath1, Karen L Krok, Dorry L Segev, Hwan Y Yoo.   

Abstract

It has been suggested that the post-liver transplantation (LT) survival rate of patients with hepatitis C virus infection (HCV) has declined in recent years. To compare the outcome of LT in patients with HCV at various time intervals between 1991 and 2001, we used United Network for Organ Sharing data to compare the post-LT survival of adult patients (age >18 years) with HCV with those without HCV. Of the 37,101 patients who underwent LT during the study period, 28,193 patients (HCV 7,459 and 20,734 non-HCV) were eligible for the study. On the basis of the time of transplantation, patients were divided into 3 groups: 1991-1993 (period 1), 1994-1997 (period 2), and 1998-2001 (period 3). The patient and graft survival rates were adjusted for other known confounding variables that influenced outcomes. The 3-year patient survival rate was lower in HCV patients compared with non-HCV recipients (78.5% vs. 81.4%, hazard ratio 1.14, 95% confidence interval 1.05-1.23, P = 0.001). The graft (72.8%, 71.0%, and 69.8%) and patient (77.4%, 79.6%, and 78.5%) survival of HCV patients remained unchanged during study periods 1-3, respectively. However, the graft and patient survival rates of non-HCV recipients improved markedly during study periods 2 and 3 compared with period 1. The graft and patient survival has remained unchanged between 1991 and 2001 in HCV recipients, but during the same period, there was a great improvement in survival among non-HCV recipients.

Entities:  

Mesh:

Year:  2007        PMID: 17457933     DOI: 10.1002/lt.21123

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  14 in total

1.  Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation.

Authors:  Jacqueline G O'Leary; James F Trotter; Michael A Neri; Linda W Jennings; Greg J McKenna; Gary L Davis; Göran B Klintmalm
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

2.  Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival.

Authors:  A DiMartini; M A Dew; D Chaiffetz; M G Fitzgerald; M E Devera; P Fontes
Journal:  Am J Transplant       Date:  2011-06       Impact factor: 8.086

3.  The impact of sirolimus on hepatitis C recurrence after liver transplantation.

Authors:  Sonal Asthana; Christian Toso; Glenda Meeberg; David L Bigam; Andrew Mason; James Shapiro; Norman M Kneteman
Journal:  Can J Gastroenterol       Date:  2011-01       Impact factor: 3.522

Review 4.  NK cells, innate immunity and hepatitis C infection after liver transplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Infect Dis       Date:  2011-02-01       Impact factor: 9.079

5.  Management of recurrent hepatitis C following liver transplantation.

Authors:  Stevan A Gonzalez
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-10

6.  Antiviral treatment for hepatitis C virus infection after liver transplantation.

Authors:  Yasuhiko Sugawara; Sumihito Tamura; Norihiro Kokudo
Journal:  Hepat Res Treat       Date:  2010-11-01

7.  Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada.

Authors:  K Ds Watt; K W Burak; M Deschênes; L Lilly; D Marleau; P Marotta; A Mason; K M Peltekian; E Renner; E M Yoshida
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

8.  Treatment of Hepatitis C Virus Infection in Liver Transplant Recipients.

Authors:  Duminda Suraweera; Vinay Sundaram; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-01

9.  Liver transplantation and hepatitis C.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Int J Hepatol       Date:  2012-07-26

10.  The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.

Authors:  Sridhar R Allam; Bernd Krüger; Anita Mehrotra; Thomas Schiano; Bernd Schröppel; Barbara Murphy
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.